Vivacta Biotechnology (Shanghai) Co., Ltd.
PrivateLast Round
Series A
Apr 29, 2026
Total Funding Raised
$50M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Vivacta Biotechnology (Shanghai) Co., Ltd. is a biotechnology company developing in vivo CAR-T therapies for cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivacta Biotechnology (Shanghai) Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Vivacta Biotechnology (Shanghai) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 29, 2026 |
Vivacta Biotechnology (Shanghai) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Loyal Valley Capital | Series A |
| Eisai Innovation | Series A |
| OrbiMed | Series A |
| Xiamen C&D Emerging Industry Equity Investment | Series A |
| Beijing Shunxi Fund | Series A |
| Hankang Capital | Series A |
| Qiming Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
$50M round led by Decheng Capital.
Vivacta Biotechnology (Shanghai) Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vivacta Biotechnology (Shanghai) Co., Ltd.'s valuation, stock price, and market status.